Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ki Tua Fund is a corporate venture capital arm of Fonterra Group focused on investing in and partnering with startups developing disruptive solutions at the intersection of science, nutrition, and technology. The fund aims to accelerate innovation that positively impacts health by leveraging Fonterra’s global expertise in dairy science and human nutrition. It manages over $100 million USD with nine portfolio companies as of 2025. Its investments span bio manufacturing innovations, gut microbiome health startups, synthetic biology ventures, and agricultural productivity technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ki Tua Fund.